Stock 4151 KYOWA KIRIN CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 08:24:45 2024-04-24 pm EDT 		5-day change 1st Jan Change
2,642 JPY -0.41% Intraday chart for Kyowa Kirin Co. Ltd. +0.59% +11.35%
Apr. 08 U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease RE
Apr. 03 Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March MT

Business Summary

Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:

- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;

- sales of licenses (7.4%).

At the end of 2021, the group had 3 production sites located in Japan (2) and China.

Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).

Number of employees: 5,974

Sales per Business

JPY in Million2022Weight2023Weight Delta
Manufactured Product
90.5 %
364,596 91.5 % 400,372 90.5 % +9.81%
Technology
9.5 %
33,775 8.5 % 41,860 9.5 % +23.94%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
38.9 %
139,852 35.1 % 172,242 38.9 % +23.16%
Japan
34.7 %
154,636 38.8 % 153,462 34.7 % -0.76%
Europe
14.9 %
62,251 15.6 % 65,745 14.9 % +5.61%
Asia
10.1 %
37,368 9.4 % 44,759 10.1 % +19.78%
Americas
1.1 %
4,053 1.0 % 5,054 1.1 % +24.70%
Other
0.2 %
210 0.1 % 972 0.2 % +362.86%

Managers

Managers TitleAgeSince
Motohiko Kawaguchi DFI
 Director of Finance/CFO - 86-03-31
Masashi Miyamoto PSD
 President 64 85-03-31
Takeyoshi Yamashita CTO
 Chief Tech/Sci/R&D Officer 62 10-03-31
Yoshifumi Torii CTO
 Chief Tech/Sci/R&D Officer 57 94-03-31
Yutaka Osawa CMP
 Compliance Officer 64 84-03-31
Takuo Hirose CTO
 Chief Tech/Sci/R&D Officer 52 18-09-30
Toshifumi Mikayama BRD
 Director/Board Member 66 08-09-30
Keiji Kuwata AUD
 Comptroller/Controller/Auditor 61 19-02-28
Hiroshi Komatsu AUD
 Comptroller/Controller/Auditor 61 12-03-31
Wataru Murata HRO
 Human Resources Officer - 83-03-31

Members of the board

Members of the board TitleAgeSince
Takashi Oyamada BRD
 Director/Board Member 68 21-02-28
Yoshihisa Suzuki BRD
 Director/Board Member 68 22-02-28
Toshifumi Mikayama BRD
 Director/Board Member 66 08-09-30
Jun Arai BRD
 Director/Board Member 65 21-02-28
Masashi Miyamoto PSD
 President 64 85-03-31
Yutaka Osawa CMP
 Compliance Officer 64 84-03-31
Takeshi Minakata BRD
 Director/Board Member 62 22-03-29
Akira Morita BRD
 Director/Board Member 73 19-02-28
Yuko Haga BRD
 Director/Board Member 68 19-02-28
Rumiko Nakata BRD
 Director/Board Member 68 23-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 540,000,000 247,790,788 ( 45.89 %) 2,390,712 ( 0.4427 %) 45.89 %

Shareholders

NameEquities%Valuation
KIRIN HOLDINGS COMPANY, LIMITED
53.49 %
288,819,000 53.49 % 5 134 M ¥
Goldman Sachs Asset Management Co., Ltd. (Japan)
0.9680 %
5,227,399 0.9680 % 93 M ¥
KYOWA KIRIN CO. LTD.
0.9177 %
4,955,614 0.9177 % 88 M ¥
Lyxor International Asset Management SAS
0.1458 %
787,437 0.1458 % 14 M ¥
I. G. Investment Management Ltd.
0.1045 %
564,200 0.1045 % 10 M ¥
Kewpie Pension Fund
0.0880 %
475,000 0.0880 % 8 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0869 %
469,500 0.0869 % 8 M ¥
Sjunde AP-fonden
0.0859 %
463,600 0.0859 % 8 M ¥
Metzler Asset Management GmbH
0.0647 %
349,185 0.0647 % 6 M ¥
SHOWA SANGYO CO., LTD.
0.0639 %
345,000 0.0639 % 6 M ¥

Holdings

NameEquities%Valuation
KYOWA KIRIN CO. LTD.
0.92%
 4,955,614 0.92% 88,097,239 $
ARDELYX, INC.
1.23%
 2,873,563 1.23% 20,977,010 $
HOKUYAKU TAKEYAMA HOLDINGS,INC.
0.21%
 52,000 0.21% 298,920 $

Company contact information

Kyowa Kirin Co., Ltd.

Otemachi Financial City Grand Cube 1-9-2 Otemachi

100-0004, Tokyo

+81 3 5205 7200

http://www.kyowa-kirin.co.jp
address Kyowa Kirin Co. Ltd.(4151)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Kyowa Kirin Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,653 JPY
Average target price
3,067 JPY
Spread / Average Target
+15.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.94% 9.18B
MERCK KGAA Stock Merck KGaA
+5.73% 71.48B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-15.34% 4.79B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+34.54% 3.98B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.97B
INDIVIOR PLC Stock Indivior PLC
+27.76% 2.56B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.33% 2.29B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-24.15% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+6.23% 1.92B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Company Kyowa Kirin Co. Ltd.